ConductScience.org, home

Paper37530985

Subsequent primary neoplasms after childhood cancer therapy - design and description of the German nested case-control study STATT-SCAR.

Scholz-Kreisel P and 16 others. Cancer Causes Control, 2024. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Subsequent primary neoplasms after childhood cancer therapy - design and description of the German nested case-control study STATT-SCAR. Papers, record 37530985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37530985

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Subsequent primary neoplasms after childhood cancer therapy - design and description of the German nested case-control study STATT-SCAR.
PubMed
Journal
Cancer Causes Control
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.22, provisional
iCite
Revised in PubMed
2024-01-06
PubMed

Authors17

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Scholz-Kreisel PPeterhttps://orcid.org/0000-0002-2838-6465
2Becker CCornelia
3Kaiser MMelanie
4Mahmoudpour SHSeyed Hamidreza
5Voigt MMathias
6Ressing MMeike
7Blettner MMaria
8Calaminus GGabriele
9Baust KKatja
10Scholtes CCathy
11Zimmermann MMartin
12Zeissig SRSylke Ruth
13Schmidberger HHeinz
14Karle HHeiko
15Meyer-Oldenburg SSarah
16Kaatsch PPeter
17Spix CClaudia

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
Neoplasms, Second PrimaryMajor topic
Child
Humans
Adolescent
Case-Control Studies

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
70112099Deutsche KrebshilfePubMed
02NUK042ABundesministerium für Bildung und ForschungPubMed

Source PubMed

Download CSV of grants

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124638000Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study.J Clin Oncol2014https://conductscience.org/library/papers/24638000PubMed
223102695Second solid cancers after radiation therapy: a systematic review of the epidemiologic studies of the radiation dose-response relationship.Int J Radiat Oncol Biol Phys2013https://conductscience.org/library/papers/23102695PubMed
322124095Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group.J Clin Oncol2012https://conductscience.org/library/papers/22124095PubMed
426972653Radiation-Related New Primary Solid Cancers in the Childhood Cancer Survivor Study: Comparative Radiation Dose Response and Modification of Treatment Effects.Int J Radiat Oncol Biol Phys2016https://conductscience.org/library/papers/26972653PubMed
520628130Long-term cause-specific mortality among survivors of childhood cancer.JAMA2010https://conductscience.org/library/papers/20628130PubMed
615712273International Classification of Childhood Cancer, third edition.Cancer2005https://conductscience.org/library/papers/15712273PubMed
711432882Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study.J Clin Oncol2001https://conductscience.org/library/papers/11432882PubMed
822672756Thyroid adenomas after solid cancer in childhood.Int J Radiat Oncol Biol Phys2012https://conductscience.org/library/papers/22672756PubMed
936975206Equivalent doses for anticancer agents used in pediatric oncology: A literature review and evaluation of a novel approach for conversion factors.Cancer Rep (Hoboken)2023https://conductscience.org/library/papers/36975206PubMed
1025715852Reconstruction of organ dose for external radiotherapy patients in retrospective epidemiologic studies.Phys Med Biol2015https://conductscience.org/library/papers/25715852PubMed
1129960606Second Malignancies Following Childhood Cancer Treatment in Germany From 1980 to 2014.Dtsch Arztebl Int2018https://conductscience.org/library/papers/29960606PubMed
1220947430Glucocorticoid use in acute lymphoblastic leukaemia.Lancet Oncol2010https://conductscience.org/library/papers/20947430PubMed
1328530852Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.J Clin Oncol2017https://conductscience.org/library/papers/28530852PubMed
1417054231Different anthracycline derivates for reducing cardiotoxicity in cancer patients.Cochrane Database Syst Rev2006https://conductscience.org/library/papers/17054231PubMed
1530306605Covariate selection strategies for causal inference: Classification and comparison.Biom J2019https://conductscience.org/library/papers/30306605PubMed
1626747086Cardiac Outcomes in Adult Survivors of Childhood Cancer Exposed to Cardiotoxic Therapy: A Cross-sectional Study.Ann Intern Med2016https://conductscience.org/library/papers/26747086PubMed
1722857014A pooled analysis of thyroid cancer incidence following radiotherapy for childhood cancer.Radiat Res2012https://conductscience.org/library/papers/22857014PubMed
1824945137Secondary malignancies in pediatric cancer survivors: perspectives and review of the literature.Int J Cancer2014https://conductscience.org/library/papers/24945137PubMed
1923940101The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study.Pediatr Blood Cancer2014https://conductscience.org/library/papers/23940101PubMed
2017367288Adverse late effects of childhood cancer and its treatment on health and performance.Annu Rev Public Health2007https://conductscience.org/library/papers/17367288PubMed

See all 39 referencesDownload CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
RPS4X6191PubTator's text mininghttps://conductscience.org/library/genes/6191

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37530985

GET https://conductscience.org/api/papers/v1/37530985/references?page=2